baber/WOPTO huggingface dataset:
Patent CA-2336662-A1 (CA)
Inventor: JANSEN JOHAN FRANZ GRADUS ANTO
IPC: C09D4/00
Filed: 1999-06-30
Abstract: L'invention concerne un composé durcissable par radiation, constituant un ester carboxylique mono ou multivalent d'un composé contenant un groupe hydroxyalkylamide et un groupe hydroxy, dans lequel l'ester carboxylique est dérivé d'un acide carboxylique insaturé en .alpha.,.beta.-éthylène. Une composition de revêtement comprenant ledit composé présente une vitesse de polarisation élevée ainsi que les propriétés chimiques et mécaniques voulues.
Patent CA-2338279-A1 (CA)
Title: Composes de liaison du recepteur d'imidazoline
Inventor: WOOD DOROTHY H
IPC: G01N33/94
Filed: 1999-06-25
Abstract: La pentamidine et les analogues de cette dernière présentent une activité comme composés de liaison du récepteur d'imidazoline. L'invention concerne un procédé de liaison du récepteur d'imidazoline. Ce procédé consiste à placer un bis-benzène en contact avec ledit récepteur d'imidazoline selon une quantité efficace pour assurer la liaison avec ledit récepteur. Ledit bis-benzène contient au moins un groupe amidine (par exemple, un ou deux). L'étape de contact peut être effectuée in vivo ou in vitro. La mise en contact peut être réalisée avec des composés actifs individuels ou avec des bibliothèques de composés actifs.
Patent CA-2340425-A1 (CA)
Inventor: AFZAL THOMAS A
IPC: A61F2/958
Filed: 1999-08-13
Abstract: Apparatus, and methods are provided for delivering oxygenated blood to a patient undergoing cardiac surgery using a perfusion catheter (65) having a distal end carrying first (71), second (72) sealing members. When the perfusion catheter is inserted through an arteriotomy site, the first, and second sealing members are disposed to engage opposite sides of a vessel (A) to apply pressure against the opposite surfaces of the thickness to seal blood perfused into the vessel from leaking through the arteriotomy site. Apparatus for placing the perfusion catheter, and methods of using the apparatus are also provided.
Patent CA-2340483-A1 (CA)
Inventor: YAMAURA KIYOSHI
IPC: H01M10/05
Filed: 2001-03-13
Abstract: A non-aqueous electrolyte cell in which structural changes of the positive electrode active material are suppressed to increase the capacity further. The non-aqueous electrolyte cell includes a positive electrode containing a lithium-transition metal compound oxide as a positive electrode active material, a negative electrode containing a carbon compound or metal lithium as a negative electrode active material and a non-aqueous electrolyte interposed between said positive and negative electrodes. The lithium-transition metal compound oxide is represented by the general formula Li x MnO2 or Li x Mn1-y Al,O2 where 0.94 ~ x _~ 0.96 and 0.06 ~ y ~  0.25.
Patent CA-2340766-A1 (CA)
Inventor: SARAVIA MARIA LILIAN
IPC: A61M25/00
Filed: 1999-08-03
Abstract: Methods for folding a catheter mounted balloon, and delivery catheter systems which incorporate radially expandable intraluminal devices (e.g., stents, grafts and stented grafts) which are mounted on a balloon folded in accordance with this method. The method comprises generally folding the balloon at least twice, in opposite directions, so that any rotational forces created by the unfolding of the balloon as it is inflated will counteract each other, and will thus avoid substantial rotational movement of the intraluminal device during its radial expansion.
Patent CA-2341014-A1 (CA)
Inventor: VILKOV BORIS NIKOLAEVICH
IPC: G11C29/00
Filed: 1998-08-19
Abstract: A transformation identification system for identification of transformation of cell addresses between different memory device topologies providing the use of minimum memory space and time required for storage and computing defect data and also the flexibility of approach offering a user friendly interface and simplification of the transformation procedure.
Patent CA-2343604-A1 (CA)
Inventor: JONES IAN KARL
IPC: B65D81/03
Filed: 2001-04-04
Abstract: A protective packaging sheet which is particularly suitable for packaging heavy loads such as coils of sheet steel. The packaging sheet is formed from a plastics sheet material having inherently relatively low compressions strength and resistance to impact forces and bending. These mechanical properties are vastly improved in the embossed packaging sheet. At least one of the surfaces of the sheet material is provided with shaped protuberances juxtaposed with adjacent shaped protuberances to provide a gap around each shaped protuberance. The shaped protuberances are arranged in such a way that all straight lines projected onto the surface cut through the shaped protuberances in addition to the gaps.
Patent CA-2347505-A1 (CA)
Title: Quenching oligonucleotides
Inventor: HAUGLAND RICHARD P
IPC: C12Q1/68
Filed: 2001-05-14
Abstract: The invention relates to oligonucleotides labeled with an energy transfer acceptor useful in conjunction with fluorescent nucleic acid stains. The resulting oligonucleotides are useful for decreasing background fluorescence during amplification assays and in ligation assays, and for detecting hybridization.
Patent CA-2355794-A1 (CA)
Title: Methode et appareil pour mettre des donnees en antememoire a l'avance dans une memoire auditive
Inventor: TAKEDA GENYO
IPC: A63F13/00
Filed: 2001-08-17
Abstract: Un système de jeu vidéo comprend un processeur de signal audio numérique, une mémoire principale et une mémoire audio distincte de la mémoire principale et le stockage des données relatives à l'audio pour un traitement par le processeur de signal audio numérique. Le circuit d'accès en mémoire lit des données non liées à l'audio stockées sur un périphérique de stockage de masse et écrit les données non liées à l'audio dans la mémoire audio. Les données non liées à l'audio sont lues plus tard de la mémoire audio et écrites dans la mémoire principale.
Patent CA-2356015-A1 (CA)
Title: Method and apparatus for encoding vouchers in a cashless casino gaming system
Inventor: MARCU ADRIAN R
IPC: G07F17/32
Filed: 2001-08-29
Abstract: The apparatus and method described herein transmits a unique machine identification number and a sequence number from a local host to a casino game via a network. In the event that the local host is unable to provide the sequence number, the casino game generates the sequence number locally. Subsequently, the casino game performs a series of numerical operations starting with the machine identification number and the sequence number to generate an encoded a voucher number. The voucher is then printed for the patron and the number is reported to the local host.
Patent CA-2357515-A1 (CA)
Inventor: BONEHAM JIM
IPC: E21B41/00
Filed: 2001-09-14
Abstract: A portable flare stack used for burning off oil and gas wells at plants batteries, and well sites. This is a trailer mounted flare stack that can be erected to forty (40) or sixty (60) feet in height depending upon industry request.
Patent CA-2360540-A1 (CA)
Title: Ductal orifice identification by characteristic electrical signal
Inventor: GROSSER MORTON
IPC: A61B5/053
Filed: 2000-01-12
Abstract: The invention provides methods and kits relating to identification of ductal orificies on a mammalian breast nipple. The methods em-ploy technology to measure characteristic electri-cal signals on a nipple surface to locate and image or map the ductal orifices on the nipple surface.  Kits are also provided comprising materials for identifying a duct by characteristic electrical sig-nal, for additionally analyzing (30) the signals, and accessing or marking the ducts once they have been identified by the characteristic elec-trical signal values.
Patent CA-2361283-A1 (CA)
Inventor: BECK JAMES JOSEPH
IPC: C12Q1/6895
Filed: 2000-02-28
Abstract: The present invention relates to the use of primers in polymerase chain reaction assays for the detection of fungal pathogens, particularly Monilinia laxa and Monilinia fructicola. Specific primers are identified as being useful for the indentification of fungal isolates, particularly Monilinia laxa and Monilinia fructicola, using PCR based techniques.
Patent CA-2364302-A1 (CA)
Inventor: REZVANI BEHZAD
IPC: G01D3/028
Filed: 2001-12-03
Abstract: A circuit includes an integrator arranged to integrate input signals over a predetermined sample period based on the cycle period of a power source signal. A delay is coupled to the integrator and is responsive to the end of a sample period to delay start of a successive sample period for a predetermined time delay to cancel low frequency noise induced into the circuit during a prior sample period.
Patent CA-2364999-A1 (CA)
Title: Method and apparatus for terminology translation
Inventor: HULL DAVID
IPC: G06F17/28
Filed: 2001-12-10
Abstract: The invention relates to a method and apparatus for generating translations of natural language terms from a first language to a second language. A plurality of terms are extracted from unaligned comparable corpora of the first and second languages. Comparable corpora are sets of documents in different languages that come from the same domain and have similar genre and content. Unaligned documents are not translations of one another and are not linked in any other way. By accessing monolingual thesauri of the first and second languages, a category is assigned to each extracted term. Then, category-to-category translation probabilities are estimated, and using said category-to-category translation probabilities, term-to-term translation probabilities are estimated. The invention preferably exploits class-based normalization of probability estimates, bi-directionality, and relative frequency normalization. The most important applications are cross-language text retrieval, semi-automatic bilingual thesaurus enhancement, and machine-aided human translation.
Patent CA-2365869-A1 (CA)
Title: Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
Inventor: TILLYER RICHARD D
IPC: A61P3/06
Filed: 2000-02-02
Abstract: The instant invention provides methods and pharmaceutical compositions for inhibiting HMG-CoA reductase, as well as for treating and/or reducing the risk for diseases and conditions affected by inhibition of HMG-CoA reductase, comprising orally administering a therapeutically effective amount of a crystalline hydrated form of the calcium salt of dihydroxy open acid simvastatin to a patient in need of such treatment. Methods for making the calcium salt of dihydroxy open acid simvastatin are also provided.
Patent CA-2369917-A1 (CA)
Title: Method and system for servicing and maintaining thermal equipment, water treatment equipment and the like
Inventor: ISHIZAKI NOBUYUKI
IPC: G06Q50/00
Filed: 2002-01-25
Abstract: There is provided a method and a system for servicing and maintaining thermal equipment, water treatment equipment and the like, which fulfills a prompt countermeasure against an abnormality. The servicing and maintenance system is provided with a communication line connecting between a facility site and a management center.      The management center is provided with a database for storing various information on the thermal equipment and/or water treatment equipment, and a control unit for reading requested information from the database in response to a request of the facility site side to provide various information and transmitting the requested information to the facility site through the communication line. Further, the facility site is provided with an information retrieval unit which is capable of requesting the control unit to provide various information through the communication line, receiving the requested information transmitted from the control unit through the communication line, and confirming contents thereof.
Patent CA-2370096-A1 (CA)
Title: Compositions and processes for oil field applications
Inventor: HAMOUDA ALY A
IPC: C09K8/58
Filed: 2000-05-22
Abstract: Encapsulated crosslinking agents and gel-forming compositions are provided that can be utilized in oil field applications. Processes for producing said encapsulated crosslinking agents and said gel-forming compositions are also provided. In addition, a process for injecting said gel-forming composition into a subterranean formation is also provided.
Patent CA-2373270-A1 (CA)
Title: Transmitter tolerant to crystal variations
Inventor: SUMMERS ANDREW GORDON
IPC: H04Q9/12
Filed: 2000-05-17
Abstract: A transmitter (800) to transmit data from an end-point includes a reference oscillator (802); a low pass filter (804) coupled to the reference oscillator (802); a modulation filter (804) to provide an over-sampled modulated signal; a synthesizer (808) coupled to the low pass filter (804) and the modulation filter (806); and a sine wave generator (812) coupled to the synthesizer (808).
Patent CA-2375986-A1 (CA)
Inventor: KOBAYASHI MOTOHIRO
IPC: C07D405/14
Filed: 2000-06-01
Abstract: Substituted pyrazole compounds of general formula (I) or salts thereof, whic h exhibit an excellent p38 MAP kinase inhibiting effect and are useful in the prevention or treatment of tumor necrosis factor .alpha.-related diseases, interleukin 1-related diseases, interleukin 6-related diseases, or cyclooxygenase II-related diseases wherein R1 is -CH(OH)-CH(R4)-(A)n-Y, -CH2 - CH(R4)-(A)n-Y, -CO-B1-A-Y, or the like (wherein A is lower alkylene; Y is ar yl which may be substituted with, e.g., halogeno, or the like; R4 is hydrogen o r lower alkyl; B1 is -CH(R4)- or -N(R4)-; and n is 0 or 1); R2 is hydrogen, lower alkyl which may be substituted with hydroxyl or the like, or aralkyl; R3 is phenyl which may be substituted with halogeno or the like, or pyridyl; an d Q is pyridyl or quinolyl.
Patent CA-2376847-A1 (CA)
Title: Complex of eletriptan and a cyclodextrin derivative
Inventor: BILLOTTE ANNE
IPC: A61K47/48
Filed: 2000-06-02
Abstract: This invention relates to a complex of eletriptan and a sulphobutylether-beta-cyclodextrin, or a pharmaceutically acceptable salt thereof, and to processes for the preparation of, pharmaceutical formulations including, and the used of, such a complex.
Patent CA-2376987-A1 (CA)
Title: Wireless communication system using access points that can be freely set up by users
Inventor: YOSHINO SHUICHI
IPC: H04W84/04
Filed: 2002-03-15
Abstract: In a wireless communication system formed by a plurality of access points constituting a wireless network, through which user terminals make accesses, and at least one control station configured to control the access points, public access points are systematically set up by a manager of the control station, while user's personal access points to be freely set up by users at desired locations according to needs of users are accommodated by operating the control station to measure a utilization level of each user's personal access point and charge an owner of each user's personal access point according to a measured utilization level and set up relay routes using the public access points and the user's personal access points.
Patent CA-2377565-A1 (CA)
Title: Transfection tres efficace utilisant une faible intensite de champ electrique et une longue duree d'impulsion
Inventor: NOLAN ED
IPC: C12N15/87
Filed: 1999-06-25
Abstract: L'invention concerne un procédé permettant l'introduction d'acide nucléique dans une cellule par la mise en contact de la cellule avec un acide nucléique et l'application d'une impulsion de faible intensité de champ électrique pendant une longue durée d'impulsion. L'invention concerne aussi un procédé permettant l'introduction d'un polypeptide dans une cellule par la mise en contact de la cellule avec le polypeptide et l'application d'une impulsion de faible intensité de champ électrique pendant une longue durée d'impulsion.
Patent CA-2379572-A1 (CA)
Inventor: OGILVIE RONALD JAMES
IPC: C07D403/06
Filed: 2000-09-14
Abstract: The present invention is concerned with a crystalline, polymorphic form of a compound of formula (I) characterised by a powder X-ray diffraction pattern obtained using copper K-alpha, radiation (.gamma.= 0.15046 nm) which shows main peaks at 9.28, 10.38, 11.37, 12.40, 16.84, 17.46, 17.53, 17.78, 17.98, 19.48. 20.70, 21.29, 21.45, 22.21, 22.64, 23.08, 25.20 and 25.79. The invention also relates to processes for the preparation of said form, to pharmaceutical compositions containing same and to its use in medicine, particularly the treatment of conditions for which an agonist of 5-IIT~ receptors is indicated, for example, migraine,
Patent CA-2379700-A1 (CA)
Inventor: MAHAJAN PRAMOD B
IPC: C12N9/90
Filed: 2000-06-13
Abstract: The invention provides isolated maize RuvB nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering maize RuvB levels in plants. The invention further provides recombinant expression cassettes, host cells, transgenic plants, and antibody compositions.
Patent CA-2380138-A1 (CA)
Title: Ventilating system, heat exchanger and methods
Inventor: HAGLID KLAS C
IPC: F24F7/08
Filed: 2002-04-03
Abstract: The ventilating system includes evaporative cooling of the exhaust air before it enters a heat exchanger to cool incoming fresh outside air. A suction fan pulls exhaust air through the heat exchanger and, in combination with a flow restrictor, reduces the pressure on the exhaust air and augments the evaporative cooling. The use of a pusher fan to force outside air through the heat exchanger ensures that any leakage in the heat-exchanger results in outside air entering exhaust air and minimizing the chances of contamination by leasing exhaust air into the incoming fresh air. The heat exchanger is made economically by heat-forming cavities in relatively thick thermo-plastic sheets, interleaving them with other thermo-plastic sheets having separate gas flow conduit structures, and securing the sheets together. Preferably, the heat-exchanger is an opposed-flow heat-exchanger giving improved heat-transfer efficiency.
Patent CA-2380294-A1 (CA)
Title: Charging for prepaid subscribers in a telecommunications system
Inventor: HAATAJA TIMO
IPC: H04M17/00
Filed: 2000-09-01
Abstract: To be able to customize subscriber charging in a telecommunications system, at least two different kinds of tariff models (TM) are defined, each model containing a tariff scheme defining how to charge a call. The tariff model to be used with a subscriber is directly or indirectly indicated in subscriber information (SI).
Patent CA-2380774-A1 (CA)
Title: Sampling filter for chlorinated organic compounds
Inventor: HONDA KATSUHISA
IPC: B01D39/16
Filed: 2001-05-28
Abstract: A sampling device (3) which can capture various chlorinated organic compound s in both forms of particles and gases contained in a fluid at the same time a nd further can easily extract the captured chlorinated organic compounds is equipped with a sampling filter (7) being disposed in a holder (6) having a discharging path (12a). The sampling filter (7) comprises fibers and an inorganic binder for binding the fibers with one another and has a structure  allowing a fluid to pass through the filter. A sample gas from a flue (25) flows into the holder (6) through a sampling tube (2) and a conduit (8), and  various chlorinated organic compounds such as PCDDs and coplanar PCBs in bot h forms of particles and gases are captured and sampled while the sample gas passes through the sampling filter (7). The sample gas from which the chlorinated organic compounds have been removed is discharged out from the discharging path (12a).
Patent CA-2380805-A1 (CA)
Title: Improved topical medicaments and methods for photodynamic treatment of disease
Inventor: WACHTER ERIC
IPC: A61P33/00
Filed: 2000-08-10
Abstract: New photodynamic, topically-applicable medicaments and certain medical uses of such photodynamic medicaments for treatment of human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene. The halogenated xanthenes constitute a family of poten t photosensitizers that become photoactivated upon illumination of the treatme nt site with visible wavelengths of light. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs; the mouth and digestive tract and related organs; t he urinary and reproductive tracts and related organs; the respiratory tract an d related organs; various other internal or external tissue surfaces, such as tissue surfaces exposed during surgery; and for treatment of a variety of conditions related to microbial or parasitic infection. In another preferred  embodiment, such medicaments are produced in various formulations including liquid, semisolid or aerosol delivery vehicles.
Patent CA-2382166-A1 (CA)
Inventor: LU HELEN S M
IPC: C07C253/10
Filed: 2000-09-19
Abstract: L'invention concerne des réactions d'hydrocyanation utilisant des ligands de phosphite polydentés, et les ligands de phosphite polydentés eux-mêmes. Ces ligands comportent des substituants phénylés reliés en position ortho du groupe phénol terminal et/ou reliés en position ortho du groupe de pontage. Les compositions catalytiques renfermant ces ligands permettent d'obtenir, par l'hydrocyanation, une distribution supérieure ou égale à 97 %.
Patent CA-2382863-A1 (CA)
Inventor: MIURA TAKASHI
IPC: C07C69/003
Filed: 2002-04-22
Abstract: A method for safely and efficiently producing high purity 3-~-menthoxypropane-1,2-diol and intermediates to be used in the method. As shown in the following reaction formula, 3-~-menthoxypropane-1,2-diol represented by the chemical formula (IV) is produced by adding ~-menthol to a 1,2-epoxy-3-halogenopropane represented by the general formula (I) (wherein X represents a halogen atom) in an organic solvent in the presence of a Lewis acid, thereby producing a 1-halogeno-3-~-menthoxypropan-2-o1 represented by the general formula (II), allowing the first intermediate to react with an alkali metal salt of an aliphatic carboxylic acid having from 1 to 5 carbon atoms to produce a 1-acyloxy-2-substituted-3-~-menthoxypropane represented by the general formula (III) and then hydrolyzing the second intermediate.
Patent CA-2383186-A1 (CA)
Title: Method to identify gene function using small molecule probes
Inventor: SAVINOV SERGEY N
IPC: C12Q1/6809
Filed: 2000-09-01
Abstract: Methods for identifying genes which bind to natural products and other small molecules using a phage display system are described. Phage displaying protein which binds the target molecule are selected by affinity chromatography using a solid support to which a small molecule non-peptide bait is coupled. The selectively bound phage can then be amplified and the DNA inserts encoding the binding protein sequenced. The specifically bound protein is then useful to screen for therapeutic candidates which can then be used to treat conditions modulated by the target protein.
Patent CA-2385515-A1 (CA)
Title: Coating agent and coated particulate fertilizers
Inventor: CIACCIO CORINNE GRADY
IPC: C05G3/00
Filed: 2000-10-27
Abstract: A coated fertilizer is provided along with a method for producing the coated fertilizer, where the coated fertilizer has a coating made of at least one amine compound which is a primary, secondary or tertiary, straight or branched hydrocarbon chain amine or an amine containing a cyclic hydrocarbon radical and a microcrystalline wax, a paraffin wax or a soft synthetic wax.